Developing a cassette microdosing approach to enhance the throughput of PET imaging agent screening

J Pharm Biomed Anal. 2018 May 30:154:48-56. doi: 10.1016/j.jpba.2018.02.063. Epub 2018 Mar 3.

Abstract

Cassette dosing is also known as N-in-One dosing: several compounds are simultaneously administrated to a single animal and then the samples are rapidly detected by LC-MS/MS. This approach is a successful strategy to enhance the efficiency of drug discovery and reduce animal usage. However, no report on the utility of the cassette approach in radiotracer discovery has appeared in the literature. This study designed a cassette microdose with LC-MS/MS method to enhance the throughput for screening radiopharmaceutical biodistribution in the rat brain directly. Three unradiolabeled compounds (FPBM FPBM2 and AV-133) were chosen as model drugs administrated intravenously to the rats as a cassette as opposed to discrete study. The rat brain biodistribution data, target localization, the differential uptake ratio (%ID/g) and the brain tissue-specific binding ratio were obtained by the LC-MS/MS analysis. These data matched very well with the values obtained by the standard radioactivity measurements. Moreover, no significant differences between discrete dosing and cassette dosing were observed. By circumventing the need for radiolabeled molecules, this method may be high-throughput and safe for the research and development of new PET imaging agents. The combination of cassette microdosing and LC-MS/MS would be a medium throughput screening tool at an early stage in the discovery/development process of PET imaging agents.

Keywords: Biodistribution; FPBM; LC–MS/MS; PET imaging agents; Positron emission tomography.

MeSH terms

  • Aniline Compounds / administration & dosage
  • Aniline Compounds / chemistry
  • Aniline Compounds / pharmacokinetics
  • Animals
  • Brain / metabolism*
  • Chromatography, High Pressure Liquid / instrumentation
  • Chromatography, High Pressure Liquid / methods
  • Drug Discovery / instrumentation
  • Drug Discovery / methods*
  • Fluorine Radioisotopes / administration & dosage
  • Fluorine Radioisotopes / chemistry
  • Fluorine Radioisotopes / pharmacokinetics
  • High-Throughput Screening Assays / instrumentation
  • High-Throughput Screening Assays / methods*
  • Male
  • Models, Animal
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals / administration & dosage
  • Radiopharmaceuticals / chemistry
  • Radiopharmaceuticals / pharmacokinetics*
  • Rats
  • Rats, Sprague-Dawley
  • Tandem Mass Spectrometry / instrumentation
  • Tandem Mass Spectrometry / methods
  • Tetrabenazine / administration & dosage
  • Tetrabenazine / analogs & derivatives
  • Tetrabenazine / chemistry
  • Tetrabenazine / pharmacokinetics
  • Tissue Distribution*

Substances

  • 2-(2-((dimethylamino)methyl)-4-(3-fluoropropoxy)phenylthio)benzenamine
  • Aniline Compounds
  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • florbenazine F 18
  • Tetrabenazine